Genetic associations in myasthenia gravis. Implications for pathogenesis
Has parts
Paper I: Journal of Neuroimmunology 210(1-2), Alseth, E. H.; Nakkestad, H. L.; Aarseth, J.; Gilhus, N. E.; Skeie, G. O., Interleukin-10 promoter polymorphisms in myasthenia gravis, pp. 63-66. Copyright 2009 Elsevier. Full text not available in BORA due to publisher restrictions. The published version is available at: http://dx.doi.org/10.1016/j.jneuroim.2009.02.009Paper II: Archives of Neurology 64(12), Amdahl, C.; Alseth, E. H.; Gilhus, N. E.; Nakkestad, H. L.; Skeie, G. O., Polygenic disease associations in thymomatous myasthenia gravis, pp. 1729-1733. Copyright 2007 American Medical Association. Full text not available in BORA due to publisher restrictions. The published version is available at: http://archneur.ama-assn.org/cgi/content/full/64/12/1729
Paper III: Muscle & Nerve 43(4), Alseth, E. H.; Maniaol, A. H.; Elsais, A.; Nakkestad, H. L.; Tallaksen, C.; Gilhus, N. E.; Skeie, G. O., Investigation for rapsyn and Dok-7 mutations in a cohort of seronegative myasthenia gravis patients. Published as: Investigation for RAPSN and DOK-7 mutations in a cohort of seronegative myasthenia gravis patients, pp. 574-577. Copyright 2011 Wiley Periodicals. Full text not available in BORA due to publisher restrictions. The published version is available at: http://dx.doi.org/10.1002/mus.21919
Publisher
The University of BergenCopyright
Copyright the author. All rights reservedThe author